Medical Economics spoke with health care attorney Tatiana Melnik, J.D., about vendor contracts, patient consent and the malpractice questions physicians could face next.
News|Articles|September 26, 2024
Physician input needed: Do you prescribe semaglutide or other GLP-1RAs?
Author(s)Medical Economics Staff
Are your patients asking about Ozempic and other GLP-1RAs? Are you prescribing it? Take our quick survey.
Advertisement
One of the hottest topics in medicine right now is the potentially revolutionary use of Glucagon-like peptide-1 receptor agonist (GLP-1RAs) drugs to manage overweight/obesity. These medicines are popularly known to patients by brand names like Ozempic or Wegovy.
We value your expertise! We're conducting a brief survey to gather insights from physicians like you on physician use and perceptions of GLP-1RA drugs for managing obesity.
Your feedback will be instrumental in helping us create content to inform physicians about this rapidly developing space.
The survey takes only 5 minutes to complete, and all responses are anonymous.
Advertisement
Related to this article
How long before every doctor has an artificial intelligence stunt double?
EBRI data show employer plans pay hospital outpatient departments about twice what physician offices receive for the same physician-administered drugs, and the commercial market has barely begun to address the gap.
Why physicians owe tax on their share of practice profit rather than the cash they take out, and how entity type, footnotes and late K-1s can change the final bill.
Report: Osteopathic profession leads youth movement as workforce grows across U.S. health care.
From a same-day payment cut to AI-run prior authorization in traditional Medicare, MGMA's government affairs team laid out what Washington has in store for physicians next year.
A joint lifetime income annuity and a fixed indexed annuity with an income rider both guarantee income for a surviving spouse, but they differ sharply on flexibility, cost and cash value
The American Medical Association and five specialty societies say casting AI as smarter than physicians diminishes their expertise, a day after the health secretary praised AI second opinions.
Advertisement
Advertisement
Trending on Medical Economics
1
GLP-1 users report more nail detachment, hair loss than nonusers, study finds
2
Six physician groups push back on claims that AI is better informed than doctors
3
What AI vendor contracts and AI scribe consent mean for physicians' legal risk
4
The HIPAA and malpractice risks physicians take on with AI tools
5